Related Experiment Video
Updated: Jun 20, 2025
Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 2, 2013
The South African Prostate Cancer Screening Guidelines
J John1, A Adam2, L Kaestner3
1Division of Urology, Department of Surgery, Faculty of Medicine and Health Sciences, Walter Sisulu University, East London, South Africa; Division of Urology, Department of Surgery, Faculty of Health Sciences, University of Cape Town, South Africa. jeffveenajohn@gmail.com.
Prostate cancer screening guidelines are updated for South African men. These evidence-based recommendations aim to improve early diagnosis and treatment while minimizing over-treatment of indolent prostate cancer (PCa).
Area of Science:
- Urology
- Oncology
- Public Health
Background:
- Prostate cancer (PCa) is a leading cause of cancer death in men globally.
- Accurate diagnosis and treatment of clinically significant PCa remain challenging, with risks of over-diagnosis and over-treatment of indolent disease.
- Existing guidelines for PCa screening and early diagnosis often rely on prostate-specific antigen (PSA) testing.
Purpose of the Study:
- To provide evidence-based recommendations for prostate cancer (PCa) screening and early diagnosis.
- To guide clinicians in South Africa on managing PCa in asymptomatic men.
- To address the challenge of identifying significant PCa while avoiding overtreatment of indolent forms.
Main Methods:
- Review and synthesis of recent evidence from large randomized prospective trials.
- Development of updated clinical recommendations by the South African Urological Association and the Prostate Cancer Foundation of South Africa.
- Focus on prostate-specific antigen (PSA) testing in the context of screening and early diagnosis.
Main Results:
- Establishment of updated, evidence-based guidelines for PCa screening and early diagnosis.
- Recommendations tailored for the South African context.
- Emphasis on balancing the benefits of early detection with the risks of overtreatment.
Conclusions:
- The updated guidelines offer crucial direction for clinicians managing prostate cancer in South Africa.
- These recommendations aim to optimize patient outcomes by improving the accuracy of PCa diagnosis and treatment.
- Adherence to these guidelines can help mitigate the over-diagnosis and over-treatment of non-life-threatening prostate cancer.
